Please assess the completion status of the following clinical trial:

Trial Title: An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Critically ill male or female subjects 18 years or older who have a baseline gastric aspirate pH less then or equal to 4~* Subjects admitted to an ICU requiring mechanically ventilated~* Subjects will have at least one additional stress ulcer risk factor~Exclusion Criteria:~* Anticipated use of pre-pyloric enteral feeding after screening until the end of study~* Physician estimated survival of less then 96 hours~* Anticipation of major surgery within 96 hours of study enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).